A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder

Completed · Phase 2 · Has a placebo group

Conditions studied: Jet Lag Disorder

In brief

A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder

Key facts

Study ID

NCT03291041

Run by

Vanda Pharmaceuticals

People needed

25

Starts

2016-07-01

Expected to finish

2017-11-01

Last updated by the study team

2021-11-03

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Ability and acceptance to provide written consent
• Men or women between 18-75 years
• Body Mass Index of ≥ 18 and ≤ 30 kg/m2

You may not qualify if…

• History (within the 12 months prior to screening) of psychiatric disorders
• Major surgery, trauma, illness or immobile for 3 or more days within the past month
• Pregnancy or recent pregnancy (within 6 weeks)
• A positive test for drugs of abuse at the screening visit
• Any other sound medical reason as determined by the clinical investigator

Where it is running

• Vanda Investigational Site — Alameda, California, United States
• Vanda Investigational Site — Santa Monica, California, United States
• Vanda Investigational Site — Chevy Chase, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.